Kristine Peterson
Director/Board Member bij IMMUNOCORE HOLDINGS PLC
Vermogen: - $ op 31-03-2024
Momenteel actieve connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Bahija Jallal | M | 62 |
Immunocore Ltd.
 Immunocore Ltd. Pharmaceuticals: MajorHealth Technology Part of Immunocore Holdings Plc, Immunocore Ltd. is a British commercial-stage biotechnology company that develops and commercializes transformative medicines to address unmet needs in cancer, infection, and autoimmune disease. The private company is based in Oxon, UK. The company has a robust pipeline of wholly owned and partnered programs to address a broad spectrum of disease indications, built on their proprietary soluble TCR bi-specific Immtac® platform. The company was founded in 2007, and the CEO is Bahija Jallal. | 5 jaar |
| Lars Ekman | M | 74 |
AFYX Therapeutics AS
 AFYX Therapeutics AS Miscellaneous Commercial ServicesCommercial Services AFYX Therapeutics AS engages in research and development of pharmaceutical drugs. It develops a platform designed to deliver a pharmaceutical drug uni-directional to a mucosal surface. The company was founded in May 2014 and is headquartered in Virum, Denmark. | 15 jaar |
| James Healy | M | 58 | 10 jaar | |
| Aaron Berg | M | 61 | 12 jaar | |
| Carl Gordon | M | 59 | 8 jaar | |
| Göran Albert Ando | M | 75 | 6 jaar | |
| John Bell | M | 71 | 9 jaar | |
| Stuart Lutzker | M | 63 | 3 jaar | |
| Zheng Bin Yao | M | 58 | 3 jaar | |
| Jonathan Light | M | - | 7 jaar | |
| Odysseas Kostas | M | 49 | 1 jaar | |
| Jay Luly | M | 67 | 21 jaar | |
| Peter Ratcliffe | M | 69 |
Immunocore Ltd.
Immunocore Ltd. Pharmaceuticals: MajorHealth Technology Part of Immunocore Holdings Plc, Immunocore Ltd. is a British commercial-stage biotechnology company that develops and commercializes transformative medicines to address unmet needs in cancer, infection, and autoimmune disease. The private company is based in Oxon, UK. The company has a robust pipeline of wholly owned and partnered programs to address a broad spectrum of disease indications, built on their proprietary soluble TCR bi-specific Immtac® platform. The company was founded in 2007, and the CEO is Bahija Jallal. | - |
| Bruce Carter | M | 80 | 11 jaar | |
| Travis Coy | M | - |
Immunocore Ltd.
Immunocore Ltd. Pharmaceuticals: MajorHealth Technology Part of Immunocore Holdings Plc, Immunocore Ltd. is a British commercial-stage biotechnology company that develops and commercializes transformative medicines to address unmet needs in cancer, infection, and autoimmune disease. The private company is based in Oxon, UK. The company has a robust pipeline of wholly owned and partnered programs to address a broad spectrum of disease indications, built on their proprietary soluble TCR bi-specific Immtac® platform. The company was founded in 2007, and the CEO is Bahija Jallal. | 5 jaar |
| Roy Herbst | M | 60 |
Immunocore Ltd.
Immunocore Ltd. Pharmaceuticals: MajorHealth Technology Part of Immunocore Holdings Plc, Immunocore Ltd. is a British commercial-stage biotechnology company that develops and commercializes transformative medicines to address unmet needs in cancer, infection, and autoimmune disease. The private company is based in Oxon, UK. The company has a robust pipeline of wholly owned and partnered programs to address a broad spectrum of disease indications, built on their proprietary soluble TCR bi-specific Immtac® platform. The company was founded in 2007, and the CEO is Bahija Jallal. | 3 jaar |
| Keith Horn | M | 66 | 1 jaar | |
| William Hait | M | 74 | 17 jaar | |
| Lars Siim | M | - |
AFYX Therapeutics AS
AFYX Therapeutics AS Miscellaneous Commercial ServicesCommercial Services AFYX Therapeutics AS engages in research and development of pharmaceutical drugs. It develops a platform designed to deliver a pharmaceutical drug uni-directional to a mucosal surface. The company was founded in May 2014 and is headquartered in Virum, Denmark. | - |
| Luke Düster | M | 49 | 8 jaar | |
| Robert Perez | M | 59 | 5 jaar | |
| Winston Kung | M | 48 | - | |
| Mark Dipaolo | M | 53 | 1 jaar | |
| Lily Hepworth | F | - | 6 jaar | |
| Christopher Bostrom | M | - | 4 jaar | |
| Diane Sullivan | F | 62 | 1 jaar | |
| Christian Nolet | M | 67 | 1 jaar | |
| Jim Kastenmayer | M | 52 | 1 jaar | |
| Jennifer Viera | F | - | 1 jaar | |
| Ron I. Honig | M | - | 6 jaar | |
| Mark Foletta | M | 63 | 4 jaar | |
| John Landis | M | 71 | 6 jaar | |
| Lesley Russell | M | 63 | 8 jaar | |
| Paul Mellett | M | 68 | 21 jaar | |
| Wendy DiCicco | F | 56 | 5 jaar | |
| David Guyer | M | 64 | 5 jaar | |
| Terry Vance | M | 67 | 13 jaar | |
| Yujiro Hata | M | 49 | 3 jaar | |
| Paul Cohen | M | 49 | 1 jaar | |
| Louis Sterling | M | 45 | 1 jaar | |
| Patrice Bonfiglio | F | 40 | 1 jaar | |
| Daniel Char | M | 63 | 2 jaar | |
| Siddharth Kaul | M | - |
Immunocore Ltd.
Immunocore Ltd. Pharmaceuticals: MajorHealth Technology Part of Immunocore Holdings Plc, Immunocore Ltd. is a British commercial-stage biotechnology company that develops and commercializes transformative medicines to address unmet needs in cancer, infection, and autoimmune disease. The private company is based in Oxon, UK. The company has a robust pipeline of wholly owned and partnered programs to address a broad spectrum of disease indications, built on their proprietary soluble TCR bi-specific Immtac® platform. The company was founded in 2007, and the CEO is Bahija Jallal. | 2 jaar |
| Elizabeth Forminard | F | 53 | 18 jaar | |
| Adam Dilluvio | M | - | 1 jaar | |
| Rob Perez | M | - |
Immunocore Ltd.
Immunocore Ltd. Pharmaceuticals: MajorHealth Technology Part of Immunocore Holdings Plc, Immunocore Ltd. is a British commercial-stage biotechnology company that develops and commercializes transformative medicines to address unmet needs in cancer, infection, and autoimmune disease. The private company is based in Oxon, UK. The company has a robust pipeline of wholly owned and partnered programs to address a broad spectrum of disease indications, built on their proprietary soluble TCR bi-specific Immtac® platform. The company was founded in 2007, and the CEO is Bahija Jallal. | - |
| John Bell | M | - |
Immunocore Ltd.
Immunocore Ltd. Pharmaceuticals: MajorHealth Technology Part of Immunocore Holdings Plc, Immunocore Ltd. is a British commercial-stage biotechnology company that develops and commercializes transformative medicines to address unmet needs in cancer, infection, and autoimmune disease. The private company is based in Oxon, UK. The company has a robust pipeline of wholly owned and partnered programs to address a broad spectrum of disease indications, built on their proprietary soluble TCR bi-specific Immtac® platform. The company was founded in 2007, and the CEO is Bahija Jallal. | - |
| Said Saim | M | 66 | 5 jaar | |
| Dan Dan Dong | M | 40 | 3 jaar | |
| Karen McGrath | F | - | 5 jaar | |
| Scott Jones | M | 57 | 5 jaar | |
| Nabil A. Abadir | M | - | 2 jaar | |
| Jennifer Taubert | F | - | 19 jaar | |
| Morten Aleksandr Engel | M | - |
AFYX Therapeutics AS
AFYX Therapeutics AS Miscellaneous Commercial ServicesCommercial Services AFYX Therapeutics AS engages in research and development of pharmaceutical drugs. It develops a platform designed to deliver a pharmaceutical drug uni-directional to a mucosal surface. The company was founded in May 2014 and is headquartered in Virum, Denmark. | - |
| Stacey Seltzer | F | 47 | 1 jaar | |
| Christian Ellebæk Elling | M | 55 |
AFYX Therapeutics AS
AFYX Therapeutics AS Miscellaneous Commercial ServicesCommercial Services AFYX Therapeutics AS engages in research and development of pharmaceutical drugs. It develops a platform designed to deliver a pharmaceutical drug uni-directional to a mucosal surface. The company was founded in May 2014 and is headquartered in Virum, Denmark. | - |
| George Elston | M | 59 | 5 jaar | |
| Yat Sun Or | M | 72 | 25 jaar | |
| Yang Wang | M | - | 3 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Leisa Swanson | F | 78 | 10 jaar | |
| Daniel Junius | M | 71 | 13 jaar | |
| John Thero | M | 63 | 12 jaar | |
| Michael J. Farrell | M | 45 | 3 jaar | |
| David B. Johnston | M | 68 | 5 jaar | |
| Karim Mikhail | M | 53 | 3 jaar | |
| Joseph Zakrzewski | M | 60 | 12 jaar | |
| Mark Enyedy | M | 60 | 8 jaar | |
| David Mazzo | M | 67 | 15 jaar | |
| William Duke | M | 51 | 4 jaar | |
| Joseph T. Kennedy | M | 56 | 10 jaar | |
| Joseph Scodari | M | 71 | 9 jaar | |
| John R. Barr | M | 67 | 3 jaar | |
| Matthew Stuckley | M | - | 14 jaar | |
| Jason Marks | M | 48 | 1 jaar | |
| John Johnson | M | 66 | 19 jaar | |
| Stephen McCluski | M | 72 | 17 jaar | |
| Lisa Romanko | F | - | 19 jaar | |
| Lisa M. DeFrancesco | F | 45 | - | |
| Douglas Pagán | M | 52 | 5 jaar | |
| Bryan Pinciaro | M | - | 1 jaar | |
| Rosemary Crane | F | 64 | 6 jaar | |
| Robert Radie | M | 60 | 9 jaar | |
| Leonard S. Ross | M | 74 | 13 jaar | |
| Evan Norton | M | 49 | 3 jaar | |
| Curtis Selquist | M | 79 | 36 jaar | |
| Mark Goldberg | M | 69 | 13 jaar | |
| Timothy Franson | M | 72 | 8 jaar | |
| Prithviraj Banerjee | M | 62 |
University of Illinois At Urbana–Champaign
| 3 jaar |
| Jeffrey Stein | M | 69 | 9 jaar | |
| Gregory Perry | M | 63 | 4 jaar | |
| Joseph Truitt | M | 59 | 4 jaar | |
| Richard Wallace | M | 72 | 17 jaar | |
| Thomas Dietz | M | 60 | 9 jaar | |
| Charles O. Prince | M | 74 | 17 jaar | |
| Robert J. Darretta | M | 78 | 39 jaar | |
| Michael Rogers | M | 64 | 14 jaar | |
| William Perez | M | 76 | 13 jaar | |
| Michael Johns | M | 82 | 9 jaar | |
| Christine Poon | F | 71 | 9 jaar | |
| Christophe Soulier | M | - | 5 jaar |
Statistieken
| Land | Connecties | % van het totaal |
|---|---|---|
| Verenigde Staten | 60 | 60.00% |
| Ierland | 19 | 19.00% |
| Australië | 11 | 11.00% |
| Verenigd Koninkrijk | 10 | 10.00% |
| Denemarken | 4 | 4.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Kristine Peterson
- Persoonlijk netwerk
